|
|
|
Pharmacyte Biotech Inc (NASDAQ: PMCB) |
|
Pharmacyte Biotech Inc
PMCB's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Pharmacyte Biotech Inc 's sales fell
in I. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 12.07 %
Pharmacyte Biotech Inc realized net income compared to net loss a year ago in I. Quarter 2024
• More on PMCB's Growth
|
|
Pharmacyte Biotech Inc
realized a net loss in trailing twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.39.
• More on PMCB's Valuation
|
|
|
|
|
Pharmacyte Biotech Inc
realized net loss in trailing twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.39.
| | | |
